As of 2025-08-12, the Relative Valuation of Alliance Pharma PLC (APH.L) is (25.79) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.70 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -139.9%.
The range of the Relative Valuation is (23.21) - (27.97) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 14.3x | 12.1x |
| Forward P/E multiples | 11.9x - 16.3x | 14.4x |
| Fair Price | (23.21) - (27.97) | (25.79) |
| Upside | -135.9% - -143.2% | -139.9% |
| Date | P/E |